Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005919 · ClinicalTrials.gov registry record

Cause of Pigment Dispersion Syndrome

A clinical trial, sponsored by National Eye Institute (NEI).

Completed
Registry status
90
Enrollment target

NCT00005919: Completed study, sponsored by National Eye Institute (NEI).

NCT00005919 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005919 has completed, sponsored by National Eye Institute (NEI).

COMPLETED
Registry status
90 participants
Enrollment target

Study Summary

The purpose of this study is to learn how pigment is released from the iris (the colored part of the eye) in patients with pigment dispersion syndrome. It will do this by examining the response of the pupil (the central opening of the iris) to a flash of light to determine what is happening in the iris to cause release of the pigment. In pigment dispersion syndrome, pigment released from the iris is deposited in other parts of the eye, including the trabecular meshwork-a filter-like tissue in the front of the eye. Aqueous fluid (fluid continuously produced by the eye) normally flows out of the eye through the trabecular meshwork. In some patients, the pigment deposits may block tiny holes in the meshwork, preventing the fluid from flowing out. This can cause an increase in eye pressure that may lead to glaucoma and some loss of vision. Understanding how pigment is released from the iris may help predict the course of pigment dispersion syndrome and identify which patients will likely develop increased eye pressure. Patients with pigment dispersion syndrome and normal volunteers may be eligible for this study. All participants will have the following procedures, which will be completed in two clinic visits: First visit 1. Examination of the front of the eyes, including the cornea, iris and lens. 2. Vision testing and measurements of visual field and eye pressure. 3. Examination of the trabecular meshwork. For this test, a contact lens is placed on the eye after the eye has been numbed with anesthetic drops. Second visit 1. Refraction (dilation of the pupils with drops) and examination of the back of the eyes, including the optic nerve. 2. Reaction of the pupils to low-level infrared light (pupillography). During this 15-minute test, the patient or volunteer wears a lightweight headband with two small cameras mounted on it. The cameras-one which views the eye and the other the subject's field of view-record pupil dilation and position. The test results in patie

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2000-06
Est. Completion 2003-08
National Eye Institute (NEI)

221 total trials

What the finished NCT00005919 record still lists

NCT00005919 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00005919 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00005919 about?

NCT00005919 is a clinical study titled "Cause of Pigment Dispersion Syndrome". The purpose of this study is to learn how pigment is released from the iris (the colored part of the eye) in patients with pigment dispersion syndrome. It will do this by examining the response of the pupil (the central opening of the iris) to a flash of light to determine what is happening in the i...

What is the current status of trial NCT00005919?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2000-06. Estimated completion is 2003-08.

Who is sponsoring clinical trial NCT00005919?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00005919, the US trial registry maintained by the National Library of Medicine. NCT00005919 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.